首页> 美国卫生研究院文献>Saudi Journal of Biological Sciences >Nano-formulation of herbo-mineral alternative medicine from
【2h】

Nano-formulation of herbo-mineral alternative medicine from

机译:纳米制剂脱脂矿物替代医学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Traditional medicine is becoming a primary source of health care in many countries in recent years. The current study proposes a new dimension of understanding a traditional origin treatment, using herbo-mineral preparations in nanoform. The herbo-mineral preparation, Linga chenduram [HMLC], was prepared according to the ancient palm script protocol dates back to 1000 years. In search of alternative therapy for the coronavirus, an attempt was made to determine this ethnic medicine formulation's therapeutic potential for viral hepatitis infection. The Hepatitis C virus [HCV] has several genomic similarities with SARS-CoV-2 viruses. The herbo-mineral formulation (HMLC) were analyzed using UV–vis, EDAX, FTIR, XRD, SEM, and TEM studies. SEM images confirmed the ' presence of nanoparticles with agglomerated conditions having an average grain size of 18 to 25 nm. EDAX studies showed the presence of metallic components in oxide or sulfide form in HMLC. The HCV inhibitory effects of HMLC indicated a good response. The cytotoxicity of this preparation against the Huh-7 human hepatoma cell line was significant. The HMLC showed a strong inhibitory effect on HCV replication in a dose-dependent manner. The genomic component of HCV is similar to COVID −19 virus. The Hepatitis C virus (HCV) NS3/4A protease has a striking three-dimensional structural similarity to the SARS-CoV2 Mpro protease, particularly in the arrangement of key active site residues. So HMLC can be tried to treat coronavirus infection. At higher concentrations, HMLC exhibited over 100-fold inhibition. In the MTT assay, HMLC did not show any apparent cytotoxic effect on cell viability at the concentrations 1–100 µg. Histological studies indicated that the liver and kidney did not experience any toxicity by 7 and 15 consecutive days of administration of HMLC on experimental Wistar rats. Hence, the HMLC can be tried as a therapy for COVID −19 infections using the preparations strictly according to ethnopharmacological protocol and optimum doses.
机译:近年来,传统医学正在成为许多国家的医疗保健的主要来源。目前的研究提出了一种在纳米型中使用脱胶矿物制剂了解传统原产地治疗的新维度。根据古老的Palm剧本议定书,Linga Chenduram [HMLC] Linga Chenduram [HMLC]恢复了1000年。寻找冠状病毒的替代治疗,试图确定这种民族制剂的病毒性肝炎感染治疗潜力。丙型肝炎病毒[HCV]具有与SARS-COV-2病毒的几种基因组相似性。使用UV-Vis,edax,FTIR,XRD,SEM和TEM研究进行分析疱疹矿物制剂(HMLC)。 SEM图像证实了纳米颗粒的存在,其具有平均晶粒尺寸为18至25nm的凝聚条件。 edax研究显示HMLC中氧化物或硫化物形式的金属组分存在。 HMLC的HCV抑制作用表明了良好的反应。该制剂对Huh-7人肝瘤细胞系的细胞毒性显着。 HMLC以剂量依赖性方式对HCV复制进行了强烈的抑制作用。 HCV的基因组成分类似于Covid -19病毒。丙型肝炎病毒(HCV)NS3 / 4A蛋白酶具有与SARS-COV2 MPRO蛋白酶引起的三维结构相似性,特别是在关键活性位点残留物的布置中。因此,可以尝试治疗冠状病毒感染。在较高浓度下,HMLC抑制超过100倍。在MTT测定中,HMLC未对浓度1-100μg的细胞活力显示任何表观细胞毒性作用。组织学研究表明,肝肾和肾脏未在实验Wistar大鼠施用HMLC的连续施用中的任何毒性。因此,HMLC可以根据民族医药方案严格使用制剂作为Covid -19感染的治疗方法,并且最佳剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号